CN102389542A - Traditional Chinese medicine for treating chronic hepatitis - Google Patents
Traditional Chinese medicine for treating chronic hepatitis Download PDFInfo
- Publication number
- CN102389542A CN102389542A CN2011102071027A CN201110207102A CN102389542A CN 102389542 A CN102389542 A CN 102389542A CN 2011102071027 A CN2011102071027 A CN 2011102071027A CN 201110207102 A CN201110207102 A CN 201110207102A CN 102389542 A CN102389542 A CN 102389542A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- traditional chinese
- parts
- chronic hepatitis
- fine powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine for treating chronic hepatitis, belonging to the field of traditional Chinese medicines for treating digestive system diseases. The traditional Chinese medicine has the characteristics of good effect and quick action. The traditional Chinese medicine is prepared from glabrous greenbrier rhizome, rhizoma atractylodis macrocephalae, ganoderma lucidum, notoginseng, red sage root, oriental wormwood, green tangerine peel and other raw materials. The traditional Chinese medicine has the effects of supporting healthy qi, strengthening body resistance, invigorating qi, nourishing blood, clearing away heat and toxic material, activating blood circulation to dissipate blood stasis and relieving pain, and has the advantages of remarkable effect, exact potency and quick action.
Description
Technical field
The invention belongs to the field of Chinese medicines of treatment digestive system disease.
Background technology
The present field of Chinese medicines that is intended to treat chronic hepatitis, the deficiency of two aspects of existence: the one, effect is obvious inadequately, and the 2nd, it is slower to take effect.So that large quantities of chronic hepatitis patients are because of can not get the treatment of active drug; Liver disease constantly develops, and clinical symptoms can not get alleviating, and the patient is seriously weak for a long time, dull pain in liver, liver function decline, hepatic fibrosis etc.; Life quality descends greatly, and I and family members are dissatisfied to this.
To problem set forth above, the present invention provides a kind of Chinese medicine of treating chronic hepatitis, and it is obvious inadequately that it can solve in this type of treatment by Chinese herbs in the past effect; The slower problem that takes effect, effective, instant effect, it is remarkable to have effect; Drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention realizes through following technical scheme:
1, a kind of Chinese medicine of treating chronic hepatitis adopts the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
Rhizoma Smilacis Glabrae 6---18 parts of 18 parts of Rhizoma Atractylodis Macrocephalaes 5---15 portions of Ganodermas 6---
Radix Notoginseng 1---18 parts of 3 parts of Radix Salviae Miltiorrhizaes 6---18 portions of Herba Artemisiae Scopariaes 6---
Pericarpium Citri Reticulatae Viride 5---15 parts
The Chinese medicine of this treatment chronic hepatitis is processed by following method:
(1) by above-mentioned weight ratio, Ganoderma is extracted ganoderan with decoction and alcohol sedimentation technique, technological process is following: Ganoderma is broken into graininess, crosses 40 mesh sieves
→Hot water (95 ℃) lixiviate with 1:20
→Lixiviating solution decompression, concentrated
→95% ethanol with 3 times of volumes mixes, left standstill 10-12 hours, centrifugal
→Add 75% ethanol, the deposition polysaccharide
→Dry the ganoderan extract fine powder;
(2) by above-mentioned weight ratio, Rhizoma Smilacis Glabrae, the Rhizoma Atractylodis Macrocephalae, Radix Salviae Miltiorrhizae, Herba Artemisiae Scopariae, Pericarpium Citri Reticulatae Viride are extracted through conventional water extraction process, process extractum, oven dry is pulverized, and gets the extract fine powder;
(3) by above-mentioned weight ratio, Radix Notoginseng is ground into fine powder, mixes, stir, process Chinese medicine granules, capsule, tablet with above-mentioned (1), (2) two kinds of extract fine powders.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.We think that the main diseases of chronic hepatitis B is because of being the heresy of epidemic disease poison at research, and promptly patient's hypoimmunity causes viral infection, outbreak inflammation, state of an illness delay, obstinate.Though under present technical conditions, still can't virus be driven away fully externally, remove totally, we can suppress it through enhancing human body immunity power, and the control virus replication reduces viral load, and this is the key of treatment primary disease.So we attach most importance to Fuzheng Jiedu, benefiting QI and nourishing blood, blood circulation promoting and blood stasis dispelling is taken good care of the liver spleen, Qinghua hot and humid ecchymosis.The maximum value of the present invention just is: it has captured difficult two " difficult problems " that heal of delay in the chronic hepatitis treatment---and the one, " dull pain in liver " that is difficult to overcome significantly alleviated even disappeared, and the 2nd, insoluble " hepatic fibrosis reverse " realizes basically or fully.This is that doctor and patient call expectation hope for many years again and again.Ganoderma, Rhizoma Atractylodis Macrocephalae the body resistance strengthening and constitution consolidating among the we, benefiting QI and nourishing blood, the pivotal role of outstanding immunity, the easing the affected liver nourishing the liver, the spleen invigorating activating the spleen, enhancing human body immunity power, " opposing " interaction energy of immunity effectively resists hepatitis B virus duplicating in vivo, reduces its quantity; Radix Salviae Miltiorrhizae, Radix Notoginseng passage, nourishing blood, promoting blood circulation, removing blood stasis and relieving pain is enriched blood with nourishing the liver and kidney, removes the stagnant heat of blood part, and " reparation " effect of immunity can be repaired impaired hepatic tissue and liver function; Be aided with the soothing the liver dispelling the stagnated QI of Pericarpium Citri Reticulatae Viride, rush down pain relieving clearly, to separate dull pain in liver; The Rhizoma Smilacis Glabrae heat-clearing and toxic substances removing, eliminating dampness and dredging channels; The soothing the liver heat clearing away of Herba Artemisiae Scopariae, eliminating damp, detoxifying is removed the damp and hot evil poison of bridle for a long time.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and heat-clearing and toxic substances removing, the merit of promoting blood circulation, removing blood stasis and relieving pain, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
Through following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
The Rhizoma Smilacis Glabrae 700 gram Rhizoma Atractylodis Macrocephalaes 600 kairine sesames 700 grams
Radix Notoginseng 100 gram Radix Salviae Miltiorrhizaes 700 gram Herba Artemisiae Scopariaes 700 grams
Pericarpium Citri Reticulatae Viride 600 grams
Press predetermined weight, Ganoderma is extracted with decoction and alcohol sedimentation technique; With conventional water extraction process Rhizoma Smilacis Glabrae, the Rhizoma Atractylodis Macrocephalae, Radix Salviae Miltiorrhizae, Herba Artemisiae Scopariae, Pericarpium Citri Reticulatae Viride are extracted, process extract fine powder 400 grams altogether, Radix Notoginseng is ground into fine powder; Mix with said extracted thing fine powder; Stir, process fine particle, the capsule of packing into No. 0; Process 1666 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.3 gram.
2, get following prescription (weight in grams is a unit):
The Rhizoma Smilacis Glabrae 1200 gram Rhizoma Atractylodis Macrocephalaes 900 kairine sesames 1200 grams
Radix Notoginseng 200 gram Radix Salviae Miltiorrhizaes 1200 gram Herba Artemisiae Scopariaes 1200 grams
Pericarpium Citri Reticulatae Viride 900 grams
By above-mentioned same method, process 2866 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.3 gram.
3, get following prescription (weight is unit by gram):
The Rhizoma Smilacis Glabrae 1800 gram Rhizoma Atractylodis Macrocephalaes 1500 kairine sesames 1800 grams
Radix Notoginseng 300 gram Radix Salviae Miltiorrhizaes 1800 gram Herba Artemisiae Scopariaes 1800 grams
Pericarpium Citri Reticulatae Viride 1500 grams
By above-mentioned same method, process 4400 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.3 gram.
4, get following prescription (by weight):
6 parts of 5 portions of Ganodermas of 6 parts of Rhizoma Atractylodis Macrocephalaes of Rhizoma Smilacis Glabrae
6 parts of 6 portions of Herba Artemisiae Scopariaes of 1 part of Radix Salviae Miltiorrhizae of Radix Notoginseng
5 parts on Pericarpium Citri Reticulatae Viride
By above-mentioned same method, process Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.3 gram.
5, get following prescription (by weight):
16 parts of 12 portions of Ganodermas of 16 parts of Rhizoma Atractylodis Macrocephalaes of Rhizoma Smilacis Glabrae
16 parts of 16 portions of Herba Artemisiae Scopariaes of 3 parts of Radix Salviae Miltiorrhizaes of Radix Notoginseng
12 parts on Pericarpium Citri Reticulatae Viride
By above-mentioned same method, process Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.3 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science chronic hepatitis, through 19 routine clinical observations.Selecting the tcm diagnosis chronic hepatitis is standard: limb is soft weak, and is weak from head to foot; Poor appetite, abdominal distention, dyspepsia; Face is pitch-dark, hepatic face is arranged; Dull pain in liver; Hepatic fibrosis is serious; It is undesired that liver function transaminase continues, and other index such as plasma albumin, blood STB etc. are unusual.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 11 examples, women's 8 examples do not have other serious disease, and the age is 47 years old-79 years old, 61.1 years old mean age.
Efficacy determination:
1, produce effects: weak alleviation, on one's body energetically; Poor appetite, abdominal distention, dull pain in liver are obviously alleviated, and the hepatic region is comfortable; Hepatic face is taken on a new look to some extent, and it is pale that face becomes; The hepatic fibrosis inspection is obviously alleviated; Indexs such as liver function test transaminase, plasma albumin are obviously improved.
2, effective: weak solution, on one's body energetically, abdominal distention, poor appetite, hepatic face are alleviated to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking the Chinese medicinal capsule that the specific embodiment of the invention 2 is made, observed 6 months, is a course of treatment.Instructions of taking: every day 2 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.3 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 6 months after, symptom is obviously improved.19 philtrums of clinical experiment, produce effects 9 people, effective 8 people, invalid 2 people, total effective rate 89.4%.
Claims (1)
1. Chinese medicine of treating chronic hepatitis is characterized in that: said Chinese medicine is to adopt the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
Rhizoma Smilacis Glabrae 6---18 parts of 18 parts of Rhizoma Atractylodis Macrocephalaes 5---15 portions of Ganodermas 6---
Radix Notoginseng 1---18 parts of 3 parts of Radix Salviae Miltiorrhizaes 6---18 portions of Herba Artemisiae Scopariaes 6---
Pericarpium Citri Reticulatae Viride 5---15 parts
The Chinese medicine of this treatment chronic hepatitis is processed by following method:
(1) by above-mentioned weight ratio, Ganoderma is extracted ganoderan with decoction and alcohol sedimentation technique, technological process is following: Ganoderma is broken into graininess, crosses 40 mesh sieves
→Hot water (95 ℃) lixiviate with 1:20
→Lixiviating solution decompression, concentrated
→95% ethanol with 3 times of volumes mixes, left standstill 10-12 hours, centrifugal
→Add 75% ethanol, the deposition polysaccharide
→Dry the ganoderan extract fine powder;
(2) by above-mentioned weight ratio, Rhizoma Smilacis Glabrae, the Rhizoma Atractylodis Macrocephalae, Radix Salviae Miltiorrhizae, Herba Artemisiae Scopariae, Pericarpium Citri Reticulatae Viride are extracted through conventional water extraction process, process extractum, oven dry is pulverized, and gets the extract fine powder;
(3) by above-mentioned weight ratio, Radix Notoginseng is ground into fine powder, mixes, stir, process Chinese medicine granules, capsule, tablet with above-mentioned (1), (2) two kinds of extract fine powders.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011102071027A CN102389542A (en) | 2011-07-23 | 2011-07-23 | Traditional Chinese medicine for treating chronic hepatitis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011102071027A CN102389542A (en) | 2011-07-23 | 2011-07-23 | Traditional Chinese medicine for treating chronic hepatitis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102389542A true CN102389542A (en) | 2012-03-28 |
Family
ID=45857007
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011102071027A Pending CN102389542A (en) | 2011-07-23 | 2011-07-23 | Traditional Chinese medicine for treating chronic hepatitis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102389542A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105250959A (en) * | 2015-10-27 | 2016-01-20 | 哈尔滨市康隆药业有限责任公司 | Traditional Chinese medicine preparation for repairing liver damage and preparation method |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101953925A (en) * | 2010-10-21 | 2011-01-26 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating chronic hepatitis |
-
2011
- 2011-07-23 CN CN2011102071027A patent/CN102389542A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101953925A (en) * | 2010-10-21 | 2011-01-26 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating chronic hepatitis |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105250959A (en) * | 2015-10-27 | 2016-01-20 | 哈尔滨市康隆药业有限责任公司 | Traditional Chinese medicine preparation for repairing liver damage and preparation method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101843694B (en) | Chinese medicament for treating chronic hepatitis | |
CN102389480A (en) | Chinese medicament for treating hepatitis | |
CN102379989A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
CN102327358A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
CN102379947A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
CN102114074A (en) | Traditional Chinese medicine for treating diabetic diarrhea | |
CN101953924A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
CN102048831A (en) | Traditional Chinese medicine for treating cirrhosis | |
CN102138969A (en) | Traditional Chinese medicine for treating diabetic diarrhea | |
CN101953925A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
CN102091165A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
CN102172375A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
CN101991685A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
CN102389479A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
CN103127272A (en) | Chinese medicinal preparation for treating breast disease and preparation method thereof | |
CN102068533A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
CN102379994A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
CN101979023A (en) | Chinese medicine for curing chronic hepatitis | |
CN102172369A (en) | Chinese medicine for treating hepatocirrhosis | |
CN102068529A (en) | Traditional Chinese medicine for treatment of prostatic hyperplasia | |
CN102389542A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
CN102138995A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
CN102048873A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
CN101979006A (en) | Chinese medicament for treating chronic hepatitis | |
CN101972330A (en) | Traditional Chinese medicine for treating chronic hepatitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120328 |